HC Wainwright Estimates Senseonics FY2030 Earnings

Senseonics Holdings, Inc. (NYSE:SENS) – Equities researchers at HC Wainwright issued their FY2030 earnings per share estimates for shares of Senseonics in a research note issued to investors on Tuesday, March 3rd. HC Wainwright analyst S. Lee expects that the company will post earnings of ($1.19) per share for the year. HC Wainwright has a “Buy” rating and a $18.50 price objective on the stock. The consensus estimate for Senseonics’ current full-year earnings is ($0.14) per share.

Several other equities analysts have also commented on the company. Barclays reissued an “overweight” rating and set a $31.00 price objective (up from $1.50) on shares of Senseonics in a research report on Wednesday, November 5th. TD Cowen reissued a “buy” rating on shares of Senseonics in a research report on Thursday, January 8th. Finally, Stifel Nicolaus set a $9.00 price objective on Senseonics in a research report on Tuesday. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, Senseonics currently has an average rating of “Buy” and an average target price of $22.70.

Senseonics Trading Down 18.1%

SENS opened at $6.82 on Wednesday. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17. Senseonics has a 52 week low of $5.25 and a 52 week high of $15.74. The stock has a market cap of $278.66 million, a PE ratio of -52.46 and a beta of 0.99. The business has a 50 day moving average of $7.19 and a 200-day moving average of $7.55.

Hedge Funds Weigh In On Senseonics

Several hedge funds and other institutional investors have recently bought and sold shares of SENS. Maven Securities LTD purchased a new position in shares of Senseonics during the second quarter valued at approximately $129,000. Hood River Capital Management LLC bought a new stake in Senseonics in the 2nd quarter worth approximately $3,775,000. Sio Capital Management LLC purchased a new stake in Senseonics during the 2nd quarter valued at $2,312,000. HBK Sorce Advisory LLC bought a new position in shares of Senseonics during the 3rd quarter valued at $39,000. Finally, Keynote Financial Services LLC boosted its stake in shares of Senseonics by 1,120.2% in the 2nd quarter. Keynote Financial Services LLC now owns 208,285 shares of the company’s stock worth $99,000 after buying an additional 191,215 shares during the last quarter. Institutional investors own 12.36% of the company’s stock.

Senseonics Company Profile

Senseonics Holdings, Inc is a medical technology company focused on the development and commercialization of innovative continuous glucose monitoring (CGM) systems for people with diabetes. Since its founding in 2011 and headquartered in Germantown, Maryland, the company has pioneered an implantable sensor designed to deliver long-term glucose readings. Senseonics’ mission centers on improving diabetes management by providing accurate, real-time data to patients and healthcare providers.

The company’s flagship offering is the Eversense CGM System, which features a small, fully implantable sensor placed beneath the skin to measure glucose levels for up to 90 days in the United States and up to 180 days in Europe.